Search results for "STING"

showing 10 items of 3756 documents

Testing utricular function by means of on-axis rotation

2005

Subjective visual vertical (SVV) estimation during on-axis rotation provides an efficient screening test of utricle function. The survey demonstrates that isolated disorders of peripheral utricular function can occur while SCC function appears normal.The present study aimed to investigate estimation of SVV during constant velocity yaw rotation (with the head held on-axis--to enhance any asymmetry between right and left utricular responses), as a useful screening test.In all, 230 patients were recruited from the dizziness clinic. For each patient, the SVV was estimated (a) while held stationary, and (b) during constant angular velocity (240 degrees/s), with the head centred on-axis. Bitherma…

AdultMalemedicine.medical_specialtyScreening testAudiologyRotationCaloric testingOtolithic MembraneReference ValuesOphthalmologyOrientationCaloric TestsMedicineHumansMass ScreeningSaccule and UtricleKinesthesisAgedbusiness.industryConstant velocityMedical screeningYawReproducibility of ResultsGeneral MedicineReflex Vestibulo-OcularMiddle AgedVestibular Function TestsIllusionsPeripheralElectrooculographyOtorhinolaryngologyVestibular Diseasesddc: 610VertigoFemalebusiness
researchProduct

Diagnostic Yield of 2 Strategies for Adult Celiac Disease Identification in Primary Care

2017

Goals: To compare the diagnostic yield and cost-consequences of 2 strategies, screening regardless of symptoms versus case finding (CF), using a point-of-care test (POCT), for the detection of celiac disease (CD) in primary care, to bridge the diagnostic gap of CD in adults. Materials and Methods: All subjects under 75 years of age who consecutively went to their general practitioners’ offices were offered POCT for anti-transglutaminase immunoglobulin A antibodies. The POCT was performed on all subjects who agreed, and then a systematic search for symptoms or conditions associated with higher risk for CD was performed, immediately after the test but before knowing the test results. The 2 …

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaAdolescentCross-sectional studyPoint-of-care testingCost-Benefit AnalysisPrimary careDisease03 medical and health sciencesprimary careYoung Adult0302 clinical medicinecase findingInternal medicineMedicineHumansMass Screening030212 general & internal medicineYoung adultMedical diagnosisAgedAged 80 and overdiseaseTransglutaminasesPrimary Health Carebusiness.industryscreeningGastroenterologyceliaMiddle AgedImmunoglobulin Acase finding; celiac disease; point-of-care test; primary care; screening; GastroenterologyCeliac DiseaseCross-Sectional StudiesPoint-of-Care TestingCase finding030211 gastroenterology & hepatologyObservational studypoint-of-care testFemalebusiness
researchProduct

Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia

2019

We analyzed the outcomes of 26 consecutive patients with acquired severe aplastic anemia (SAA) undergoing peripheral blood stem cell transplantation (PBSCT) with partial ex vivo T cell depletion with a targeted T cell dose from HLA-identical sibling donors. The median patient age was 37 years (range, 3 to 63 years). Four patients with uncontrolled pneumonia at the time of transplantation died, on days +1, +2, +21, and +26. All evaluable patients engrafted, with a median time to neutrophil recovery of 11 days (range, 10 to 14 days) and a median time to platelet recovery of 19 days (range, 8 to 53 days). Two patients had transient grade I acute graft-versus-host disease (GVHD) with skin invol…

AdultMalemedicine.medical_specialtySevere aplastic anemiaAdolescentT-LymphocytesT cellGraft vs Host DiseaseHuman leukocyte antigenSeverity of Illness IndexGastroenterologyDisease-Free SurvivalLymphocyte DepletionHLA AntigensInternal medicinemedicineHumansCumulative incidenceSiblingChildAllogeneic stem cell transplantation Ex vivo T cell depletion Matched sibling donor Severe aplastic anemiaEx vivo T cell depletionMatched sibling donorPeripheral Blood Stem Cell TransplantationTransplantationbusiness.industryHistocompatibility TestingSiblingsAnemia AplasticHematologyMiddle AgedAllograftsmedicine.diseaseSevere Aplastic AnemiaTissue DonorsAllogeneic stem cell transplantationSurvival RateTransplantationPneumoniasurgical procedures operativemedicine.anatomical_structureChild PreschoolAcute DiseasebusinessEx vivoFollow-Up StudiesBiology of Blood and Marrow Transplantation
researchProduct

Basal metabolic rate in narcoleptic patients.

2009

PATIENTS SUFFERING FROM NARCOLEPSY TEND TO BE OBESE.1,2 AMONG OTHER HYPOTHESES LOWER RESTING ENERGY EXPENDITURE HAS BEEN SUSPECTED to be the cause of the narcolepsy-associated obesity.3,4 The use of indirect calorimetry is a well-established noninvasive method to measure the energy expenditure (EE) and the resting (basal) metabolic rate (BMR). Chabas et al. recently published an evaluation of eating behavior and energy balance of 7 typical and 6 atypical narcoleptic patients and 9 controls using indirect calorimetry. Narcoleptic patients were found to have a lower energy expenditure (EE) than controls (n = 13, P = 0.07). Thus, it was concluded that narcolepsy associated obesity could be the…

AdultMalemedicine.medical_specialtyShort NoteLower energyBody Mass IndexBasal (phylogenetics)Physiology (medical)Internal medicineGermanymedicineHumansResting energy expenditureObesityNarcolepsyCalorimetry Indirectmedicine.diseaseObesityEndocrinologyBasal metabolic rateMetabolic rateFemaleNeurology (clinical)Basal MetabolismPsychologyEnergy MetabolismBody mass indexNarcolepsySleep
researchProduct

Effect of consumption of a carob pod inositol-enriched beverage on insulin sensitivity and inflammation in middle-aged prediabetic subjects.

2016

This study assessed the effects of an inositol-enriched beverage (IEB) on blood glucose levels and inflammation status in subjects with an impaired fasting glucose (IFG) state according to body mass index (BMI). This was a 12 week, double-blind, randomized, controlled trial employing forty-four IFG subjects (fasting glucose levels 100-125 mg dl-1) that were divided into two intervention groups: one receiving a IEB (n = 24) containing mainly pinitol (2.0 g twice a day), and the other a sweetened beverage based on sucrose (SB; n = 20). Anthropometric and biochemical measurements, postprandial and fasting nocturnal glycaemia (continuous glucose monitoring system), and inflammatory parameters (…

AdultMalemedicine.medical_specialtySucrosemedicine.medical_treatment030209 endocrinology & metabolism030204 cardiovascular system & hematologyGalactansBeveragesMannansPrediabetic State03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInsulin resistanceDouble-Blind MethodInternal medicinePlant GumsmedicineHumansAgedGlycated HemoglobinInflammationPinitolbusiness.industryInsulinGeneral MedicineAnthropometryMiddle AgedImpaired fasting glucosemedicine.diseaseEndocrinologyPostprandialchemistryFemaleInsulin ResistancebusinessBody mass indexInositolFood ScienceFoodfunction
researchProduct

Enhanced Recovery after Implementation of Surgery Protocol in Living Kidney Donors: The ISMETT Experience

2019

Abstract Introduction Laparoscopic living donor nephrectomy (LLDN) has become the standard procedure for living kidney transplantation. Enhanced recovery after surgery (ERAS) is a multimodal perioperative management aimed at facilitating rapid patient recovery after major surgery by modifying the response to stress induced by exposure to surgery. This association can further reduce hospital stay, surgical stress, and perioperative morbidity of living kidney donors. Material and methods In this retrospective analysis conducted at our institute, we compared the first 21 patients who underwent LLDN enrolled with the ERAS protocol with 55 patients who underwent LLDN with the fast-track protocol…

AdultMalemedicine.medical_specialtySurgical stressNephrectomyPatient ReadmissionPostoperative ComplicationsEnhanced recoveryISMETTLiving DonorsMedicineHumansKidney transplantationAgedRetrospective StudiesProtocol (science)TransplantationKidneybusiness.industryRetrospective cohort studyPerioperativeRecovery of FunctionLength of StayMiddle Agedmedicine.diseaseKidney TransplantationSurgerymedicine.anatomical_structureTissue and Organ HarvestingSurgeryFemaleLaparoscopybusiness
researchProduct

Lack of association of the -463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patients.

2007

Objective. To investigate potential associations between the � 463G/A myeloperoxidase (MPO) promoter polymorphism and susceptibility to, and clinical expression of, Behcet's disease (BD). Methods. One hundred and seventy-five Italian patients who satisfied the International Study Group criteria for BD and 235 healthy age- and sex-matched blood donors were genotyped for the �463G/A promoter polymorphism of the MPO gene by molecular methods. The patients were subgrouped according to the presence or absence of clinical manifestations. Results. The distribution of allele and genotype frequencies of the MPO �463A/G polymorphism did not differ significantly between the BD patients and the healthy…

AdultMalemedicine.medical_specialtySystemic diseaseAdult; Behcet Syndrome; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heterozygote; Histocompatibility Testing; Humans; Male; Peroxidase; Promoter Regions Genetic; Polymorphism GeneticHeterozygoteGenotypeBehcet's diseaseBehçet's disease; Disease manifestation; Myeloperoxidase; Myeloperoxidase gene polymorphism; Adult; Behcet Syndrome; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heterozygote; Histocompatibility Testing; Humans; Male; Peroxidase; Promoter Regions Genetic; Polymorphism Genetic; Rheumatology; Pharmacology (medical)Promoter RegionsRheumatologyGeneticGene FrequencyInternal medicineGenotypemedicineHumansPharmacology (medical)Genetic Predisposition to DiseaseAllelePolymorphismPromoter Regions GeneticPeroxidasePolymorphism Geneticbiologybusiness.industryBehcet SyndromeHistocompatibility TestingOdds ratiomedicine.diseaseRheumatologyGenotype frequencyMyeloperoxidaseImmunologybiology.proteinFemalebusinessRheumatology (Oxford, England)
researchProduct

A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine

2005

In this randomized trial renal transplant recipients were treated with basiliximab, everolimus 3 mg/day, low-dose CsA. At transplantation, patients were randomized to stop steroids at the seventh day (group A) or to continue oral steroids in low doses (group B). Of the 113 patients enrolled, 65 were randomized to group A and 68 to group B. All patients were followed for 2 years. During the study 28 (43%) group A patients required reintroduced corticosteroids. One patient died, in group B. The Graft survival rate was 97% in group A and 90% in group B. There were more biopsy-proven rejections in group A (32% vs 16%; P = .044). The mean creatinine clearance was 54 +/- 21 mL/min in group A vs 5…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentBasiliximabUrologyRenal functionGroup AGroup Blaw.inventionRandomized controlled triallawAdrenal Cortex HormonesHLA AntigensmedicineLiving DonorsHumansEverolimuscyclosporineAgedSirolimusTransplantationEverolimusbusiness.industryHistocompatibility TestingeverolimuMiddle Agedrenal transplantationKidney TransplantationSurgerySteroid Avoidance in Renal Transplant PatientsTransplantationRegimentrial; transplant; immunosoppressivesteroid avoidanceSurgeryFemalebusinessImmunosuppressive Agentsmedicine.drugFollow-Up Studies
researchProduct

Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy

2007

An inverse association either between depression or impaired functional status and quality of life (QoL) has been reported for cancer patients, but the independent effect of depression or depressive symptoms and of functional impairment on QoL is unclear.We investigated the prevalence of depression or depressive symptoms with the Beck Depression Inventory (BDI), the functional impairment with the ECOG-Performance-Status (ECOG-PS) and the QoL with the EORTC-QLQ-C30 questionnaire in a sample of 175 hospitalised cancer patients prior to the start of chemotherapy.Sixteen of 175 patients (9.1%) screened positive for major depression, 29 (16.6%) had mild to moderate depressive symptoms. In 11 of …

AdultMalemedicine.medical_specialtyTime FactorsAdolescentPsychometricsPsychometricsHealth StatusQuality of lifeNeoplasmsSurveys and QuestionnairesInternal medicinePrevalencemedicineHealth Status IndicatorsHumansRadiology Nuclear Medicine and imagingPsychological testingProspective StudiesKarnofsky Performance StatusProspective cohort studyLife StyleneoplasmsFatigueDepression (differential diagnoses)AgedAged 80 and overAnalysis of VarianceDepressive Disorder MajorPsychological TestsUnivariate analysisDepressionbusiness.industryBeck Depression InventoryCancerHematologyGeneral MedicineMiddle Agedmedicine.diseaseHealth SurveyshumanitiesOncologyQuality of LifePhysical therapyFemalebusinessActa Oncologica
researchProduct

Results of the performance verification of the CoaguChek XS system.

2008

Abstract Background This is the first paper reporting a performance verification study of a point-of-care (POC) monitor for prothrombin time (PT) testing according to the requirements given in chapter 8 of the International Organization for Standardization (ISO) 17593:2007 standard “Clinical laboratory testing and in vitro medical devices — Requirements for in vitro monitoring systems for self-testing of oral anticoagulant therapy”. The monitor under investigation was the new CoaguChek XS system which is designed for use in patient self testing. Its detection principle is based on the amperometric measurement of the thrombin activity generated by starting the coagulation cascade using a rec…

AdultMalemedicine.medical_specialtyTime FactorsCoefficient of variationPoint-of-Care SystemsThromboplastinYoung AdultCoagulation cascadeAcceptance testingReference ValuesmedicineHumansIn patientInternational Normalized RatioBlood testingBlood CoagulationOral anticoagulationAgedReagent StripsProthrombin timeAged 80 and overmedicine.diagnostic_testbusiness.industryAnticoagulantsHematologyMiddle AgedRecombinant ProteinsSurgerySelf CareOral anticoagulantProthrombin TimeFemaleDrug MonitoringbusinessBiomedical engineeringThrombosis research
researchProduct